Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · cited 1×
“The antiphospholipid syndrome (APS) is characterized by venous and arterial thrombosis and/or pregnancy morbidity occurring in patients with persistently positive antiphospholipid (aPL) antibodies [1].”
BackgroundSelf-citationRovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Asherson, R. A., Cervera, R., de Groot, P. G., Erkan, D., Boffa, M.-C., Piette, J.-C., Khamashta, M. A., Shoenfeld, Y., & Catastrophic Antiphospholipid Syndrome Registry Project Group (2003) · Lupus · doi:10.1191/0961203303lu394oa · Cited by 865
Self-citationUpdated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Bucciarelli, S., Espinosa, G., Cervera, R., Erkan, D., Gómez‐Puerta, J. A., Ramos‐Casals, M., Font, J., & Asherson, R. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22018 · Cited by 334
Self-citationRituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
Ramos-Casals, M., Soto, M., Cuadrado, M., & Khamashta, M. (2009) · Lupus · doi:10.1177/0961203309106174 · Cited by 304
Erkan, D., Vega, J., Ramón, G., Kozora, E., & Lockshin, M. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37759 · Cited by 279
Self-citationCatastrophic antiphospholipid syndrome: Updated diagnostic algorithms
Erkan, D., Espinosa, G., & Cervera, R. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.08.005 · Cited by 195
Self-citationCambridge, G., Isenberg, D. A., Edwards, J. C. W., Leandro, M. J., Migone, T.-S., Teodorescu, M., & Stohl, W. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.079418 · Cited by 193
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Erkan, D., Aguiar, C. L., Andrade, D., Cohen, H., Cuadrado, M. J., Danowski, A., Levy, R. A., Ortel, T. L., Rahman, A., Salmon, J. E., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.053 · Cited by 322
Self-citationDiagnosis and classification of the antiphospholipid syndrome
Gómez-Puerta, J. A., & Cervera, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.006 · Cited by 303
Self-citationAntiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 265
Cervera, R. (2017) · Thrombosis Research · doi:10.1016/s0049-3848(17)30066-x · Cited by 258
Self-citationCervera, R., Rodríguez-Pintó, I., Colafrancesco, S., Conti, F., Valesini, G., Rosário, C., Agmon-Levin, N., Shoenfeld, Y., Ferrão, C., Faria, R., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.03.002 · Cited by 213
Self-citationThe antiphospholipid syndrome in patients with systemic lupus erythematosus
Pons-Estel, G. J., Andreoli, L., Scanzi, F., Cervera, R., & Tincani, A. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.004 · Cited by 201
“Eculizumab has also been shown to give a long lasting remission in patients with recurrent CAPS [129,130].”
BackgroundInfluentialSelf-citationThe antiphospholipid syndrome: still an enigma
Chaturvedi, S., & McCrae, K. R. (2015) · Hematology · doi:10.1182/asheducation-2015.1.53 · Cited by 51
Wang, C.-R., & Liu, M.-F. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.02.002 · Cited by 41
The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome
Wincup, C., & Ioannou, Y. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00362 · Cited by 39
“Catastrophic APS (CAPS) represents the most acute and severe manifestation of APS.”
BackgroundInfluential
Metadata
- Authors
- Berman, H., Rodríguez-Pintó, I., Cervera, R., Morel, N., Costedoat-Chalumeau, N., Erkan, D., Shoenfeld, Y., & Espinosa, G.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 12
- Issue
- 11
- Pages
- 1085-1090
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2087207343
- Cited by
- 259
- References
- 22
- FWCI
- 17.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.